Ryan Langston
Stock Analyst at TD Cowen
(1.23)
# 3,576
Out of 4,457 analysts
230
Total ratings
47.5%
Success rate
-0.7%
Average return
Main Sectors:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Maintained: Buy | $431 | $392.33 | +9.86% | 15 | Jun 25, 2026 | |
| THC Tenet Healthcare | Rated: Buy | $242 → $233 | $187.17 | +24.49% | 8 | Jun 25, 2026 | |
| UHS Universal Health Services | Rated: Buy | $230 → $197 | $147.02 | +34.00% | 16 | Jun 22, 2026 | |
| ADUS Addus HomeCare | Reiterated: Buy | $131 | $98.05 | +33.61% | 22 | Jun 18, 2026 | |
| EHC Encompass Health | Maintained: Buy | $125 | $100.90 | +23.89% | 2 | Jun 16, 2026 | |
| SGRY Surgery Partners | Maintained: Buy | $20 → $17 | $16.56 | +2.66% | 11 | May 27, 2026 | |
| PIII P3 Health Partners | Rated: Hold | $3 → $14 | $11.94 | +17.25% | 10 | May 22, 2026 | |
| ASTH Astrana Health | Reiterated: Buy | $35 → $45 | $45.03 | -0.07% | 12 | May 12, 2026 | |
| DVA DaVita | Rated: Hold | $144 → $201 | $219.70 | -8.51% | 11 | May 11, 2026 | |
| PRVA Privia Health Group | Maintained: Buy | $30 | $25.55 | +17.42% | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $38 → $47 | $64.54 | -27.18% | 16 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 | $23.26 | +7.48% | 9 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $173 → $211 | $388.90 | -45.74% | 14 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $24 | $27.69 | -13.33% | 13 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $144 → $163 | $229.54 | -28.99% | 17 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 | $388.03 | +3.08% | 14 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $311 → $337 | $419.82 | -19.73% | 16 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $15 | $115.15 | -86.97% | 8 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 → $391 | $278.74 | n/a | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 | $10.34 | n/a | 1 | Aug 9, 2024 |
HCA Healthcare
Jun 25, 2026
Maintained: Buy
Price Target: $431
Current: $392.33
Upside: +9.86%
Tenet Healthcare
Jun 25, 2026
Rated: Buy
Price Target: $242 → $233
Current: $187.17
Upside: +24.49%
Universal Health Services
Jun 22, 2026
Rated: Buy
Price Target: $230 → $197
Current: $147.02
Upside: +34.00%
Addus HomeCare
Jun 18, 2026
Reiterated: Buy
Price Target: $131
Current: $98.05
Upside: +33.61%
Encompass Health
Jun 16, 2026
Maintained: Buy
Price Target: $125
Current: $100.90
Upside: +23.89%
Surgery Partners
May 27, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $16.56
Upside: +2.66%
P3 Health Partners
May 22, 2026
Rated: Hold
Price Target: $3 → $14
Current: $11.94
Upside: +17.25%
Astrana Health
May 12, 2026
Reiterated: Buy
Price Target: $35 → $45
Current: $45.03
Upside: -0.07%
DaVita
May 11, 2026
Rated: Hold
Price Target: $144 → $201
Current: $219.70
Upside: -8.51%
Privia Health Group
May 11, 2026
Maintained: Buy
Price Target: $30
Current: $25.55
Upside: +17.42%
May 4, 2026
Rated: Hold
Price Target: $38 → $47
Current: $64.54
Upside: -27.18%
May 4, 2026
Rated: Buy
Price Target: $25
Current: $23.26
Upside: +7.48%
May 1, 2026
Rated: Hold
Price Target: $173 → $211
Current: $388.90
Upside: -45.74%
Apr 24, 2026
Reiterated: Buy
Price Target: $22 → $24
Current: $27.69
Upside: -13.33%
Apr 24, 2026
Rated: Hold
Price Target: $144 → $163
Current: $229.54
Upside: -28.99%
Apr 24, 2026
Maintained: Buy
Price Target: $400
Current: $388.03
Upside: +3.08%
Apr 23, 2026
Rated: Hold
Price Target: $311 → $337
Current: $419.82
Upside: -19.73%
Feb 27, 2026
Maintained: Hold
Price Target: $25 → $15
Current: $115.15
Upside: -86.97%
Nov 1, 2024
Maintained: Buy
Price Target: $400 → $391
Current: $278.74
Upside: n/a
Aug 9, 2024
Rated: Hold
Price Target: $7
Current: $10.34
Upside: n/a